You are here

degludec

Degludec And Liraglutide: 2 Drivers Of Novo Nordisk's Growth

Seeking Alpha

Tue, 11/13/12 - 12:11 pm

Novo Aims for Tresiba U.S. Approval in First Half of 2013

Bloomberg

Fri, 11/9/12 - 11:07 am

FDA panel recommends approval of Novo degludec insulin

Reuters

Thu, 11/8/12 - 09:52 pm

advisory panels

FDA staff highlight heart risk with Novo insulin

Reuters

Tue, 11/6/12 - 10:12 am

Novo Nordisk says FDA disclosed focus of upcoming panel meeting

The Fly on the Wall

Fri, 10/26/12 - 10:32 am

advisory panels

FDA panel to weigh heart safety of Novo's new insulin

Reuters

Thu, 10/25/12 - 05:33 pm

advisory panels

Novo's long-acting insulin degludec takes big step to megamarket status

Fierce Biotech

Fri, 10/19/12 - 12:20 pm

Novo faces new hurdle in long-acting insulin race

Reuters

Wed, 07/18/12 - 11:52 am

long-acting insulin

Sanofi, Novo Nordisk, Amylin all tout diabetes treatments at ADA

Fierce Pharma

Mon, 06/11/12 - 01:17 pm

FDA extends review of Novo Nordisk's Degludec by 3 mths

Reuters

Fri, 06/8/12 - 11:49 am

Novo Files Degludec in Japan

Yahoo/Zacks.com

Wed, 12/28/11 - 10:47 am

Novo Nordisk: Market Fears Create A Buying Opportunity

Seeking Alpha

Wed, 10/5/11 - 10:46 am

Nordisk Seeks Approval For Degludec Insulin In Europe And US

NASDAQ.com

Wed, 09/28/11 - 11:33 am

Novo Nordisk Presents Degludec Data

Yahoo/Zacks.com

Mon, 09/19/11 - 05:59 pm

Novo Confirms Potential in New Insulin but Challenges Remain

Seeking Alpha

Thu, 02/3/11 - 09:54 am

Phase 2 data for ultra-long-acting insulin degludec show the potential to effectively lower blood sugar, including when used three times a week

Pharmaceutical Processing

Sat, 06/26/10 - 10:15 am

type 1 diabetes